One Year On: The Russia-Ukraine War


The OECD estimates that the Russia-Ukraine War will cost the global economy $2.8 trillion over the course of 2022 to 2023. Senior Editor Jacob Ambrose Willson asks a collection of Criticaleye Board Mentors their thoughts on how the conflict is reshaping the world and what it means for business strategy 

Featuring Commentary From: 

Venkataramanan Anantharaman, Chair, Ecom Express 
 
Tim Eggar, Chair, North Sea, Transition Authority
 
Mary Jo Jacobi, NED, Savannah Resources
 
Dariusz Kucz, NED, PZ Cussons
 
Mark Spelman, NED, Buro Happold
 

Share this with your Community


Contributors
Dariusz Kucz
Board Mentor
Criticaleye
Mark Spelman
Board Mentor
Criticaleye
Mary Jo Jacobi
Board Mentor
Criticaleye
Tim Eggar
Board Mentor - Emeritus
Criticaleye
Venkataramanan Anantharaman
Board Mentor
Criticaleye


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

High-energy Leadership

Donal Murphy, CEO of DCC plc, has led a large-scale transformation over the last 18 months. He talks to Criticaleye's Marc Barber about why the company's future lies in energy  As a young man...


Criticaleye Asia Podcast - HR as a Strategic Partner in Complexity

In this episode, Yu-Wen Hsiao, Marketing and Communications Manager, APAC at Criticaleye, speaks with Kathleen Kee, VP, HR – EMEA & Asia at Santen, about what it takes to lead people and performance in an i...


Inspiring Leaders Podcast: Risk in the Boardroom

In this episode, Sally Bridgeland, Chair, Development Bank of Wales, Nest Invest and BelleVie Care and Keith Cochrane, Chair, Schenck Process Group talk about what risks will be on the Board agenda this yea...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 184




NATS Legal & General AlixPartners Lightsource bp British Land LACE Partners London Stock Exchange Group Rolls-Royce NatWest Group Worldpay Hitachi Solutions Mayborn Group Aldermore Group Drax Group plc E.ON UK GlaxoSmithKline plc Canaccord Genuity Group Inc